182 related articles for article (PubMed ID: 3095376)
1. Natural history of intrahepatic canine islet cell autografts.
Alejandro R; Cutfield RG; Shienvold FL; Polonsky KS; Noel J; Olson L; Dillberger J; Miller J; Mintz DH
J Clin Invest; 1986 Nov; 78(5):1339-48. PubMed ID: 3095376
[TBL] [Abstract][Full Text] [Related]
2. The effect of transplantation site and islet mass on long-term survival and metabolic and hormonal function of canine purified islet autografts.
Scharp DW; Marchetti P; Swanson C; Newton M; McCullough CS; Olack B
Cell Transplant; 1992; 1(2-3):245-54. PubMed ID: 1344296
[TBL] [Abstract][Full Text] [Related]
3. Purified canine islet autografts. Functional outcome as influenced by islet number and implantation site.
Kaufman DB; Morel P; Field MJ; Munn SR; Sutherland DE
Transplantation; 1990 Sep; 50(3):385-91. PubMed ID: 2169662
[TBL] [Abstract][Full Text] [Related]
4. Markedly reduced beta-cell function does not result in insulin resistance in islet autografted dogs.
Tobin BW; Lewis JT; Tobin BL; Rajotte RV; Finegood DT
Diabetes; 1992 Sep; 41(9):1172-81. PubMed ID: 1499868
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic transplanted islets in humans secrete insulin in a coordinate pulsatile manner directly into the liver.
Meier JJ; Hong-McAtee I; Galasso R; Veldhuis JD; Moran A; Hering BJ; Butler PC
Diabetes; 2006 Aug; 55(8):2324-32. PubMed ID: 16873697
[TBL] [Abstract][Full Text] [Related]
6. Acceleration of chronic failure of intrahepatic canine islet autografts by a short course of prednisone.
Rilo HL; Carroll PB; Zeng YJ; Fontes P; Demetris J; Ricordi C
Transplantation; 1994 Jan; 57(2):181-7. PubMed ID: 8310505
[TBL] [Abstract][Full Text] [Related]
7. Prevention of primary nonfunction of canine islet autografts by treatment with pravastatin.
Arita S; Nagai T; Ochiai M; Sakamoto Y; Shevlin LA; Smith CV; Mullen Y
Transplantation; 2002 Jan; 73(1):7-12. PubMed ID: 11792971
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic islet autografts in dogs function despite completely diverting portacaval shunt.
Callery MP; Kamei T; Flye MW; Davis C; Swanson C; Olack B; Lacy PE; Scharp DW
Transplant Proc; 1990 Apr; 22(2):767-70. PubMed ID: 2109398
[No Abstract] [Full Text] [Related]
9. Weight-corrected islet counts are predictive of outcome in the canine intrahepatic islet autograft model.
Munn SR; Kaufman DB; Meloche RM; Field MJ; Sutherland DE
Diabetes Res; 1988 Nov; 9(3):121-4. PubMed ID: 2854030
[TBL] [Abstract][Full Text] [Related]
10. The metabolic response of intrasplenic islet autografts.
Merrell RC; Marincola F; Maeda M; Cobb L; Basadonna G
Surg Gynecol Obstet; 1985 Jun; 160(6):552-6. PubMed ID: 3923638
[TBL] [Abstract][Full Text] [Related]
11. Suppression, stress, and accommodation of transplanted islets of Langerhans.
Merrell RC; Maeda M; Basadonna G; Marincola F; Cobb L
Diabetes; 1985 Jul; 34(7):667-70. PubMed ID: 3924694
[TBL] [Abstract][Full Text] [Related]
12. Decreased chronic failure of intraperitoneal impure islets versus intrahepatic pure islets in a canine autograft model.
Wahoff DC; Nelson LA; Papalois BE; Curtis DA; Gores PF; Sutherland DE
Transplant Proc; 1995 Dec; 27(6):3186. PubMed ID: 8539902
[No Abstract] [Full Text] [Related]
13. The use of an approved biodegradable polymer scaffold as a solid support system for improvement of islet engraftment.
Kin T; O'Neil JJ; Pawlick R; Korbutt GS; Shapiro AM; Lakey JR
Artif Organs; 2008 Dec; 32(12):990-3. PubMed ID: 19133030
[TBL] [Abstract][Full Text] [Related]
14. Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass.
Teuscher AU; Kendall DM; Smets YF; Leone JP; Sutherland DE; Robertson RP
Diabetes; 1998 Mar; 47(3):324-30. PubMed ID: 9519735
[TBL] [Abstract][Full Text] [Related]
15. Canine islet autografts: functional outcome as influenced by islet number and purity.
Kaufman DB; Morel P; Field MJ; Tzardis P; Munn SR; Sutherland DE
Transplant Proc; 1990 Apr; 22(2):771-4. PubMed ID: 2109399
[No Abstract] [Full Text] [Related]
16. A method for large-scale, high-yield isolation of canine pancreatic islets of Langerhans.
Noel J; Rabinovitch A; Olson L; Kyriakides G; Miller J; Mintz DH
Metabolism; 1982 Feb; 31(2):184-7. PubMed ID: 6176832
[TBL] [Abstract][Full Text] [Related]
17. Assessment of long-term (1 year) graft survival and metabolic and hormonal changes after intrasplenic canine pancreatic microfragment transplantation.
Marchetti P; Olack B; Swanson C; Newton M; Scharp DW
Diabete Metab; 1993; 19(1):17-24. PubMed ID: 8504880
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of canine segmental pancreatic autografts.
Cutfield RG; Polonsky K; Olson L; Kyriakides G; Miller J; Mintz DH
Diabetes; 1985 Feb; 34(2):174-8. PubMed ID: 2857144
[TBL] [Abstract][Full Text] [Related]
19. Effects of cyclosporine on insulin secretion and insulin sensitivity in dogs with intrasplenic islet autotransplants.
Kneteman NM; Marchetti P; Tordjman K; Bier DM; Santiago JV; Swanson CJ; Olack BJ; Scharp DW
Surgery; 1992 Apr; 111(4):430-7. PubMed ID: 1557689
[TBL] [Abstract][Full Text] [Related]
20. Persistence of oscillatory insulin secretion in denervated islet cell autografts.
Shapiro ET; Strasser S; Polonsky KS; Alejandro R; Mintz DH
Transplantation; 1991 Sep; 52(3):574-6. PubMed ID: 1897038
[No Abstract] [Full Text] [Related]
[Next] [New Search]
